APA Citation

Kadaru, T., & Shibli-Rahhal, A. (2021). Zoledronic Acid after Treatment with Denosumab is Associated with Bone Loss within 1 Year. J Bone Metab.

Citação norma Chicago

Kadaru, Tarun, and Amal Shibli-Rahhal. "Zoledronic Acid After Treatment With Denosumab Is Associated With Bone Loss Within 1 Year." J Bone Metab 2021.

MLA Citation

Kadaru, Tarun, and Amal Shibli-Rahhal. "Zoledronic Acid After Treatment With Denosumab Is Associated With Bone Loss Within 1 Year." J Bone Metab 2021.

Advarsel: Disse citationer er muligvist ikke 100% nøjagtige.